Extragonadal actions of chorionic gonadotropin

Area of Science:

• Reproductive Endocrinology
• Oncology
• Maternal-Fetal Medicine

Background:

• Human chorionic gonadotropin (hCG) is the primary embryonic signal in primates, traditionally linked to corpus luteum rescue.
• Recent research reveals hCG receptors in extragonadal tissues and identifies multiple hCG variants (native hCG, hyperglycosylated hCG (hyp-hCG), hCG-free β).
• These findings establish significant extragonadal roles for hCG beyond its reproductive functions.

Purpose of the Study:

• To explore the diverse extragonadal functions of hCG and its variants.
• To highlight the implications of hCG in pregnancy maintenance, complications, and oncological applications.
• To underscore the diagnostic and therapeutic potential of hCG in various medical conditions.

Main Methods:

• Review of existing literature on hCG's extragonadal actions.
• Analysis of hCG's role in placental, uterine, and fetal development.
• Investigation of hCG's involvement in pregnancy complications and tumor development.

Main Results:

• hCG mediates critical functions in pregnancy, including trophoblast development, endometrial growth, immune modulation, and uterine signaling.
• Altered hCG responses are associated with recurrent pregnancy loss, pre-eclampsia, and endometriosis.
• Hyperglycosylated hCG (hyp-hCG) is implicated in trophoblastic and non-trophoblastic tumor development.
• hCG and its variants serve as markers for pre-eclampsia, Down's syndrome, gestational trophoblastic disease, and cancer.

Conclusions:

• Extragonadal hCG functions are extensive, impacting pregnancy initiation, maintenance, and complications.
• hCG variants have significant roles in both normal pregnancy and pathological conditions, including cancer.
• Further investigation into hCG's extragonadal actions promises novel diagnostic and therapeutic strategies.